| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $116.10 | $23.89 | 385.99% | 219.06x | 55.25x | 14.73x | 17.78x | 1.59x | $106.92M | 0.87% | $705.78M | 6.70 | $12.45B | 1,586.82 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.92 | $8.16 | 229.85% | 128.19x | 60.18x | 7.57x | 15.34x | 1.10x | $39.15M | 1.11% | $220.58M | 1.69 | $3.46B | 76.30 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $75.08 | $17.21 | 336.24% | 70.17x | 64.23x | 6.93x | 8.96x | 1.79x | $182.84M | 3.14% | $654.15M | 8.43 | $5.69B | 47.44 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $255.96 | $79.96 | 220.11% | 41.96x | 37.96x | 7.12x | 25.29x | 1.45x | $793.95M | 2.32% | $1.35B | 10.14 | $35.53B | 30.12 | ||
| HALO | HALOZYME THERAPEUTICS INC | $113.90 | $70.71 | 61.08% | 31.99x | 12.61x | 8.03x | 90.06x | 0.61x | $806.22M | 6.04% | $143.54M | 1.22 | $14.91B | 20.75 | ||
| VCEL | VERICEL CORP | $39.71 | $7.94 | 399.83% | 82.73x | 70.95x | 6.62x | 5.50x | 2.03x | $61.66M | 3.04% | $370.04M | 7.25 | $2.00B | 45.42 | ||
| KRYS | KRYSTAL BIOTECH INC | $345.82 | $83.43 | 314.48% | 41.82x | 44.30x | 23.18x | 7.53x | 2.23x | $257.78M | 2.52% | $1.36B | 46.03 | $9.82B | 42.08 | ||
| RPRX | ROYALTY PHARMA PLC | $58.21 | $35.95 | 61.91% | 30.96x | 10.64x | 10.22x | 3.42x | 0.63x | $2.92B | 11.29% | $9.79B | 21.99 | $41.62B | 35.39 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.26 | $18.52 | 225.42% | 158.58x | 20.83x | 3.42x | 1.85x | 1.05x | $738.18M | 6.33% | $6.32B | 32.68 | $14.98B | 38.83 | ||
| TGTX | TG THERAPEUTICS INC | $57.43 | $22.28 | 157.78% | 18.65x | 57.79x | 10.18x | 14.55x | 2.08x | $17.39M | 0.21% | $604.08M | 4.26 | $9.06B | 65.07 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.04 | $7.56 | 45.97% | 11.62x | 10.15x | 4.80x | 3.01x | 1.01x | $82.01M | 12.55% | $217.65M | 3.68 | $511.77M | 6.62 | ||
| MDXG | MIMEDX GROUP INC | $4.67 | $1.27 | 269.13% | 116.75x | -26.93x | 1.94x | 3.15x | 1.27x | $44.50M | 6.45% | $216.00M | 1.46 | $562.07M | 24.64 | ||
| EXEL | EXELIXIS INC | $58.16 | $29.82 | 95.06% | 17.68x | 17.58x | 5.99x | 7.82x | 1.16x | $1.17B | 8.04% | $1.84B | 7.35 | $14.30B | 13.14 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $301.52 | $85.31 | 253.42% | 29.94x | 31.92x | 20.82x | 6.21x | 2.27x | $130.62M | 2.16% | $967.52M | 48.22 | $6.14B | 21.99 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $237.95 | $179.14 | 32.83% | 15.59x | 9.31x | 3.27x | 3.22x | 0.64x | $1.62B | 10.77% | $4.80B | 75.98 | $18.22B | 11.27 | ||
| ADMA | ADMA BIOLOGICS INC | $9.38 | $6.93 | 35.28% | 13.03x | 11.79x | 4.18x | 5.15x | 0.76x | $116.47M | 5.44% | $408.21M | 1.79 | $2.16B | 9.28 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $526.19 | $147.44 | 256.89% | 30.36x | 27.49x | 10.61x | 6.59x | 2.28x | $3.80B | 2.84% | $20.25B | 79.81 | $129.20B | 23.48 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $788.04 | $425.23 | 85.32% | 18.79x | 14.05x | 5.21x | 2.56x | 0.99x | $3.76B | 4.64% | $31.71B | 308.48 | $81.38B | 14.15 | ||
| UTHR | UNITED THERAPEUTICS CORP | $475.45 | $187.44 | 153.65% | 15.72x | 17.79x | 6.42x | 3.19x | 2.88x | $1.09B | 5.40% | $6.40B | 150.24 | $18.59B | 11.09 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.26 | $29.91 | 37.97% | 13.14x | 9.90x | 2.49x | 2.40x | 0.78x | $354.90M | 14.85% | $999.24M | 17.25 | $2.01B | 7.17 | ||
| TECH | BIO-TECHNE CORP | $72.61 | $16.18 | 348.72% | 62.06x | 34.95x | 9.32x | 5.40x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.41B | 32.82 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.23 | $1.38 | -10.83% | 8.79x | -2.77x | 1.52x | 1.62x | 0.49x | $19.58M | 27.48% | $44.20M | 0.76 | $22.90M | 3.00 | ||
| VCYT | VERACYTE INC | $45.43 | $11.65 | 289.81% | 31.55x | 23.36x | 6.47x | 2.63x | 2.65x | $165.99M | 4.57% | $1.39B | 17.36 | $3.39B | 24.28 | ||
| INCY | INCYTE CORP | $123.89 | $58.54 | 111.63% | 15.26x | 34.95x | 4.27x | 3.96x | 1.71x | $1.92B | 7.74% | $6.34B | 31.66 | $21.16B | 10.23 |